Ding Ke, Wang Wei, Kang Ye, Zhang Lei, Tan Shuo, Tang Zhengyan
The Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
The Department of Urology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Int J Gen Med. 2022 Jun 7;15:5547-5556. doi: 10.2147/IJGM.S365210. eCollection 2022.
To illustrate the transperitoneal laparoscopic unroofing (TLU) and compare the efficacy and safety of TLU to fenestration under seminal vesiculoscopy (FUSV) in treating symptomatic seminal vesicle cyst (SVC).
We retrospectively reviewed all patients with symptomatic SVC who underwent TLU or FUSV between 2008 and 2020 at 3 institutions in Hunan. The two groups were evaluated with reference to radiological failure-free survival (R-FFS), fertility outcome, symptoms, and complications at a median 33.5-month follow-up.
Of the 98 males, 58 (59.2%) received TLU, and 40 (40.8%) underwent FUSV. Baseline characteristics were comparable. Semen analysis, prostatitis-like symptoms, and the maximum diameter of cyst were partially improved after both surgeries at 12-month follow-up. The TLU groups suggested a higher incidence rate of fertility for SVC patients with comorbid infertility compared with the FUSV group (82.4% vs 70.3%, p = 0.041), as well as better R-FFS of cysts at five-year follow-up (Log rank test, p = 0.021). In addition, the number of patients with NIH-CPSI (National Institutes of Health Chronic Prostatitis Symptom Index) scores higher than 15 decreased more significantly after TLU (p = 0.004). Except for hematospermia within 3 months, no significant difference in adverse events was observed in the two groups during the long-term follow-up.
TLU was superior for patients with large and symptomatic SVC to FUSV, with more relieved symptoms, better R-FFS of cysts and fertility outcomes.
ChiCTR2100053850 in Chinese Clinical Trial Registry Platform (ChiCTR).
阐述经腹膜腹腔镜去顶术(TLU),并比较TLU与精囊镜开窗术(FUSV)治疗症状性精囊囊肿(SVC)的疗效和安全性。
我们回顾性分析了2008年至2020年期间在湖南3家机构接受TLU或FUSV治疗的所有症状性SVC患者。在中位33.5个月的随访期内,参照影像学无失败生存率(R-FFS)、生育结局、症状和并发症对两组进行评估。
98例男性患者中,58例(59.2%)接受了TLU,40例(40.8%)接受了FUSV。基线特征具有可比性。在12个月随访时,两种手术术后精液分析、类前列腺炎症状及囊肿最大直径均有部分改善。TLU组合并不孕的SVC患者生育发生率高于FUSV组(82.4%对70.3%,p = 0.041),且在五年随访时囊肿的R-FFS更好(对数秩检验,p = 0.021)。此外,TLU术后美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)评分高于15分的患者数量下降更显著(p = 0.004)。除3个月内出现血精外,两组在长期随访期间不良事件无显著差异。
对于大型症状性SVC患者,TLU优于FUSV,症状缓解更明显,囊肿的R-FFS及生育结局更好。
中国临床试验注册平台(ChiCTR)的ChiCTR2100053850